In MM, nutlin-3 has demonstrated potent antimyeloma activity in WT TP53 cells in vitro and ex vivo, through the induction of p53 downstream targets like p21, MDM2, and the pro-apoptotic genes, BAK, BAX and PUMA [78,143,151]. This evidence concerns the gene CDKN1A and Miyoshi myopathy.